Moreover, multivariate and univariate Cox analyses of these clinical factors or RPL32 expression levels demonstrated that RPL32 expression was a potential predictor of HCC patient prognosis (Figure 3B–E). Here, RPL32 is linked to hepatocellular carcinoma.